<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/16513C09-7140-413B-AF1F-A7A878ADB3B9"><gtr:id>16513C09-7140-413B-AF1F-A7A878ADB3B9</gtr:id><gtr:name>CARLSBERG GROUP</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/16513C09-7140-413B-AF1F-A7A878ADB3B9"><gtr:id>16513C09-7140-413B-AF1F-A7A878ADB3B9</gtr:id><gtr:name>CARLSBERG GROUP</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DB036394-9034-4494-9006-922B3027AFDA"><gtr:id>DB036394-9034-4494-9006-922B3027AFDA</gtr:id><gtr:firstName>Gerd</gtr:firstName><gtr:surname>Wagner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701861"><gtr:id>89235C0C-9E84-4488-BA3A-7B1138092357</gtr:id><gtr:title>Novel Tools for Glycobiology - Integrating Chemical and Genetic Approaches</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701861</gtr:grantReference><gtr:abstractText>When bacteria attack the human body, the first contact is often made through little antennae on the surface of the invader. Similar antennae are also used by cancer cells when they spread within the body, and by cells of the immune system when an inflammatory reaction spins out of control. Whatever the nature of the individual organism or cell, these antennae are, perhaps surprisingly, made of molecular building blocks very similar in structure to the molecules ordinary sugar is made of. However, the antennae found on bacteria and cancer cells are much more complex than ordinary sugar. A complex machinery, a group of enzymes called glycosyltransferases, inside the bacteria and cancer cells is required to put them together. In our research, we use a combination of chemistry and molecular biology to take apart the glycosyltransferase machinery and understand the role of the individual parts. Ultimately, a better understanding of the glycosyltransferase machinery will give us a handle on treating infections and cancers more efficiently.</gtr:abstractText><gtr:technicalSummary>Glycosyltransferases are important biosynthetic enzymes involved in many biological processes underpinning human health and disease, including carcinogenesis, inflammation and infection. At present, our understanding of this large and complex enzyme family (20,000+ members) remains fragmented. In this project, a combination of chemical and genetic approaches will be used to advance research into therapeutically relevant glycosyltransferases. A general glycosyltransferase assay will be established to facilitate the discovery of novel, therapeutically interesting glycosyltransferase inhibitors. In addition, complementary pairs of donor analogues and glycosyltransferase mutants will be generated for the in vivo investigation of individual glycosyltransferases in complex glycosylation networks.</gtr:technicalSummary><gtr:fund><gtr:end>2009-11-09</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-11-10</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>69430</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carlsberg Group</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Carlsberg Research Centre</gtr:department><gtr:description>Carlsberg Laboratory</gtr:description><gtr:id>F259964B-8DA1-4C68-A4C8-A248600488BE</gtr:id><gtr:impact>This collaboration is multidisciplinary: Wagne group - synthetic and medicinal chemistry, Palcic group - biological assays. Results from this ongoing collaboration have contributed to two published articles (Nature Chem. Biol. 2010, 6, 321-323, ChemBioChem 2010, 11, 1392-1398), with another one submitted to J Med Chem currently in revision.</gtr:impact><gtr:partnerContribution>Monica Palcic at the Carlsberg has carried out biological tests with compounds we have developed in this project, She has also provided us with research materials (e.g. plasmids for enzymes) and has hosted the visit of a postodoctoral researcher from my group for training in protein expression and enzyme assays.</gtr:partnerContribution><gtr:piContribution>We have provided chemical compounds for evaluation in biological assays.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carlsberg Group</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Carlsberg Research Centre</gtr:department><gtr:description>Carlsberg Laboratory</gtr:description><gtr:id>883EFA0B-6E78-4467-9D6D-06DE43BE5E63</gtr:id><gtr:impact>Results from the ongoing collaboration with the Palcic group have recently lead to the discovery of a novel class of glycosyltransferase inhibitor. A manuscript on these exciting results, submitted to Nature Chemical Biology, was reviewed extremely positively by the referees and is currently under revision (A novel UDP-Gal derivative interferes with loop closure and virtually eliminates sugar transfer in glycosyltransferases - a new strategy for the development of mechanism-based inhibitors. T. Pesnot, R. Jorgensen, M. M. Palcic, G. K. Wagner*; submitted to Nat. Chem. Biol., currently in revision.)</gtr:impact><gtr:partnerContribution>It was an essential component of this Discipline Hopping Award to establish and develop the collaboration with Prof Monica Palcic, a world leader in the field of glycosyltransferase biochemistry, enzymology and molecular biology at the Carlsberg Research Centre. I visited the Palcic lab for 3 months in 2008, to learn essential techniques in glycosyltransferase cloning, expression and purification. The proteins produced during this visit were subsequently used for biological studies with new chemical probes, in the second part of this project. The collaboration with the Palcic group is ongoing, providing me with continuous access to plasmids and proteins and with the expertise to set up glycosyltransferase expression and purification protocols in my own laboratory.</gtr:partnerContribution><gtr:piContribution>The Palcic group has provided me with training and expertise in protein biochemistry and molecular biology. I have provided to the collaboration chemical probes and inhibitors, which were evaluated biologically, both in my own laboratory and at the Carlsberg Centre, with enzymes from the Palcic group.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Bugs vs Man: Who's winning now? - KCL Christmas Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A03F22C8-6E5A-4BA0-847F-FA4E9A4AA1E8</gtr:id><gtr:impact>I gave a talk entitled &amp;quot;Bugs vs Man: Who's winning now?&amp;quot; on the current status of antibiotics, antibiotics resistance, and work in my lab in these areas. The talk was for an audience of 6th formers as part of the annual Christmas Lecture of the King's College School of Natural and Mathematical Sciences. Ca 100 pupils registered for this event.

One of the purposes of the Christmas Lectures is to stimulate interest among pupils in the sciences and motivate them to study for a HE degree at the College.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>14500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Research Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>2C5A94BF-FB3F-4B88-8C13-67D74409E6DE</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>91850</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant (Screening Carbohydrate-Active Enzymes - a Fluorescent Solution)</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>27B5E485-B9FE-4B03-8E9B-B2376FC171EE</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>King's Health Partners R&amp;amp;D Challenge Fund</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>King?s Health Partners</gtr:fundingOrg><gtr:id>9B55925D-3A38-48A5-B893-6A885BC4A67A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Cancer Research Technology (CRT)</gtr:department><gtr:description>Cancer Research Technology Pump-Prime Award</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>7B16E234-B276-4D42-9CFB-EEE93585BFDD</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195964</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant (A New and Simple Screening Tool for Antibacterial Drug Discovery)</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0F4A2F61-9C67-4628-A43E-B96EF688FF05</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2120</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Society for Antimicrobial Chemotherapy vacation scholarship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>British Society for Antimicrobial Chemotherapy</gtr:fundingOrg><gtr:id>E519A233-2917-4F05-A97A-F221BA2D24C9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have prepared and biologically evaluated a novel class of inhibitors and fluorescent probes for glycosyltransferases. In future, these novel tools will be used for biological studies on this important class of enzymes, specifically for the development of glycosyltransferase bioassays.</gtr:description><gtr:id>F3010CFD-734E-4958-9BEF-2D18C488D29E</gtr:id><gtr:impact>Discovery of a novel class of glycosyltransferase inhibition (manuscrit submitted to Nature Chemical Biology, currently under revision).</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>glycosyltransferase inhibitors and fluorescent probes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61AE7CEE-4160-40AA-AEF9-9706922CA900"><gtr:id>61AE7CEE-4160-40AA-AEF9-9706922CA900</gtr:id><gtr:title>Base-modified UDP-sugars reduce cell surface levels of P-selectin glycoprotein 1 (PSGL-1) on IL-1?-stimulated human monocytes.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6d94f8e2088d5ea6f02ffaaf373f9c6"><gtr:id>a6d94f8e2088d5ea6f02ffaaf373f9c6</gtr:id><gtr:otherNames>Kanabar V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2AF94E3-970C-402A-9B09-704A7D55E733"><gtr:id>A2AF94E3-970C-402A-9B09-704A7D55E733</gtr:id><gtr:title>Inhibition of galactosyltransferases by a novel class of donor analogues.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f3a6495413874d97d9f0ec3ef60b6322"><gtr:id>f3a6495413874d97d9f0ec3ef60b6322</gtr:id><gtr:otherNames>Descroix K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B89036DB-B801-4EAC-9E6B-02DCA4F8C06E"><gtr:id>B89036DB-B801-4EAC-9E6B-02DCA4F8C06E</gtr:id><gtr:title>A novel fluorescent probe for retaining galactosyltransferases.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12a99e9e43525209b857e7cb1e5708d3"><gtr:id>12a99e9e43525209b857e7cb1e5708d3</gtr:id><gtr:otherNames>Pesnot T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BF18ADD-2BE7-4850-A366-69A040AF858A"><gtr:id>8BF18ADD-2BE7-4850-A366-69A040AF858A</gtr:id><gtr:title>The first C-glycosidic analogue of a novel galactosyltransferase inhibitor.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f3a6495413874d97d9f0ec3ef60b6322"><gtr:id>f3a6495413874d97d9f0ec3ef60b6322</gtr:id><gtr:otherNames>Descroix K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D1E6F93A-BF60-4950-B623-37C28DFFB0E3"><gtr:id>D1E6F93A-BF60-4950-B623-37C28DFFB0E3</gtr:id><gtr:title>Structural and mechanistic basis for a new mode of glycosyltransferase inhibition.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12a99e9e43525209b857e7cb1e5708d3"><gtr:id>12a99e9e43525209b857e7cb1e5708d3</gtr:id><gtr:otherNames>Pesnot T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701861</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>